Testosterone therapy has long been associated with men’s health, but it’s now gaining attention as a potential solution for women’s symptoms during menopause. Produced primarily by the ovaries and adrenal glands, testosterone levels naturally decline in women after their mid-thirties.
Women need testosterone too, just in smaller amounts, and research suggests that topping up these levels can make a significant difference in energy, mood, and sexual desire. However, current treatments are limited to hypoactive sexual desire disorder (HSDD) in post-menopausal women.
Studies have found that testosterone therapy can help alleviate symptoms such as cognitive function, bone density, pain, and migraines. Women who receive this treatment report increased energy, motivation, decreased joint pain, mental clarity, and improved mood.
While testosterone therapy is not yet widely available, it’s an off-label treatment that advocates are pushing for to be added to the Pharmaceutical Benefits Scheme (PBS). Currently, men have nine testosterone products listed on the PBS, while women have none. A petition has garnered over 10,000 signatures, highlighting the need for equal access to safe and regulated treatments.
The cost of testosterone therapy can be prohibitive, with prices exceeding $100 per tube. However, recent additions to the PBS may provide hope that testosterone is next on the list. As research continues to grow, it’s essential to consult a qualified healthcare professional before starting any new treatment.
Source: https://www.womensweekly.com.au/health/testosterone-hormone-therapy